The Latest Regenerative Medicine Articles from Streetwise Reports

Biopharma Co. Ceases Program to Optimize Resources

Research Report
  ()
This French developer of investigative cancer therapies is focused on advanced its remaining programs and is amply funded to do so, noted an Oppenheimer report.

Co.'s New Cell Therapy Shows Positive Effects

Research Report
  ()
Disease response and survival rates are impressive in updated results from several studies, noted an H.C. Wainwright & Co. report.

Follow-up Results From T2 Diabetes Trial Positive

Research Report
  ()
One year out, overall efficacy was 93% in the patients treated with a new autologous immunotherapy, noted a ROTH Capital Partners report.

Biotech Improves Efficiency of Its New Immunotherapy

Research Report
  ()
The enhancements the company made to its investigative therapy that uses a patient's own immune cells were independently validated, noted a ROTH research report.

Data on New Cell Therapy for LBCL Encouraging, Analyst Says

Research Report
  ()
The biopharma behind the investigational treatment plans to advance it into a potentially pivotal clinical program next year, noted a BTIG report.

Showing Results: 1 to 5 of 5